nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—CYP11A1—uterine cancer	0.372	0.659	CbGaD
Dinoprostone—CYP19A1—uterine cancer	0.192	0.341	CbGaD
Dinoprostone—SLC22A2—Progesterone—uterine cancer	0.0672	0.433	CbGbCtD
Dinoprostone—SLC22A1—Progesterone—uterine cancer	0.0584	0.376	CbGbCtD
Dinoprostone—CYP1A2—Progesterone—uterine cancer	0.0204	0.132	CbGbCtD
Dinoprostone—PTGFR—corpus luteum—uterine cancer	0.00966	0.0921	CbGeAlD
Dinoprostone—CYP1A2—Etoposide—uterine cancer	0.00915	0.059	CbGbCtD
Dinoprostone—CYP11A1—corpus luteum—uterine cancer	0.00736	0.0702	CbGeAlD
Dinoprostone—CYP19A1—corpus luteum—uterine cancer	0.00478	0.0456	CbGeAlD
Dinoprostone—Bimatoprost—AKR1C3—uterine cancer	0.00281	1	CrCbGaD
Dinoprostone—CYP19A1—semen—uterine cancer	0.00224	0.0214	CbGeAlD
Dinoprostone—PTGIR—artery—uterine cancer	0.00194	0.0185	CbGeAlD
Dinoprostone—PTGER2—myometrium—uterine cancer	0.0016	0.0152	CbGeAlD
Dinoprostone—SLC51B—endometrium—uterine cancer	0.00151	0.0144	CbGeAlD
Dinoprostone—PTGER3—myometrium—uterine cancer	0.00133	0.0127	CbGeAlD
Dinoprostone—PTGER2—uterine cervix—uterine cancer	0.00124	0.0119	CbGeAlD
Dinoprostone—PTGER4—epithelium—uterine cancer	0.00123	0.0117	CbGeAlD
Dinoprostone—PTGER4—smooth muscle tissue—uterine cancer	0.00119	0.0113	CbGeAlD
Dinoprostone—PTGER2—decidua—uterine cancer	0.00118	0.0113	CbGeAlD
Dinoprostone—PTGER4—decidua—uterine cancer	0.00116	0.0111	CbGeAlD
Dinoprostone—HPGDS—myometrium—uterine cancer	0.00115	0.0109	CbGeAlD
Dinoprostone—PTGER4—renal system—uterine cancer	0.00114	0.0109	CbGeAlD
Dinoprostone—PTGER2—endometrium—uterine cancer	0.00112	0.0107	CbGeAlD
Dinoprostone—PTGER4—endometrium—uterine cancer	0.0011	0.0105	CbGeAlD
Dinoprostone—PTGER1—renal system—uterine cancer	0.0011	0.0105	CbGeAlD
Dinoprostone—PTGER2—mammalian vulva—uterine cancer	0.00109	0.0104	CbGeAlD
Dinoprostone—PTGFR—myometrium—uterine cancer	0.00106	0.0101	CbGeAlD
Dinoprostone—PTGER2—uterus—uterine cancer	0.00104	0.00988	CbGeAlD
Dinoprostone—PTGER4—uterus—uterine cancer	0.00102	0.0097	CbGeAlD
Dinoprostone—PTGER3—smooth muscle tissue—uterine cancer	0.001	0.00958	CbGeAlD
Dinoprostone—PTGER3—renal system—uterine cancer	0.000967	0.00922	CbGeAlD
Dinoprostone—PTGER2—female reproductive system—uterine cancer	0.000932	0.00889	CbGeAlD
Dinoprostone—PTGER4—female reproductive system—uterine cancer	0.000914	0.00872	CbGeAlD
Dinoprostone—HPGDS—epithelium—uterine cancer	0.000901	0.00859	CbGeAlD
Dinoprostone—SLC51A—female reproductive system—uterine cancer	0.000898	0.00857	CbGeAlD
Dinoprostone—HPGDS—uterine cervix—uterine cancer	0.000893	0.00852	CbGeAlD
Dinoprostone—PTGER1—female reproductive system—uterine cancer	0.000883	0.00842	CbGeAlD
Dinoprostone—Hypertonia—Progesterone—uterine cancer	0.000869	0.00784	CcSEcCtD
Dinoprostone—PTGER3—uterus—uterine cancer	0.000861	0.00822	CbGeAlD
Dinoprostone—HPGDS—decidua—uterine cancer	0.000851	0.00812	CbGeAlD
Dinoprostone—Vaginal infection—Medroxyprogesterone Acetate—uterine cancer	0.000848	0.00765	CcSEcCtD
Dinoprostone—PTGER2—female gonad—uterine cancer	0.000848	0.00809	CbGeAlD
Dinoprostone—PTGER2—vagina—uterine cancer	0.000842	0.00804	CbGeAlD
Dinoprostone—HPGDS—renal system—uterine cancer	0.000836	0.00797	CbGeAlD
Dinoprostone—PTGER4—female gonad—uterine cancer	0.000832	0.00794	CbGeAlD
Dinoprostone—SLCO3A1—myometrium—uterine cancer	0.000826	0.00788	CbGeAlD
Dinoprostone—Cramps of lower extremities—Medroxyprogesterone Acetate—uterine cancer	0.000826	0.00744	CcSEcCtD
Dinoprostone—SLCO2A1—myometrium—uterine cancer	0.000818	0.0078	CbGeAlD
Dinoprostone—SLC51A—vagina—uterine cancer	0.000812	0.00775	CbGeAlD
Dinoprostone—HPGDS—endometrium—uterine cancer	0.000808	0.00771	CbGeAlD
Dinoprostone—PTGER1—female gonad—uterine cancer	0.000804	0.00766	CbGeAlD
Dinoprostone—PTGFR—smooth muscle tissue—uterine cancer	0.000803	0.00766	CbGeAlD
Dinoprostone—HPGDS—mammalian vulva—uterine cancer	0.000781	0.00745	CbGeAlD
Dinoprostone—PTGER3—female reproductive system—uterine cancer	0.000774	0.00739	CbGeAlD
Dinoprostone—Hot flush—Progesterone—uterine cancer	0.00077	0.00694	CcSEcCtD
Dinoprostone—Menopausal symptoms—Progesterone—uterine cancer	0.000763	0.00688	CcSEcCtD
Dinoprostone—SLCO4A1—myometrium—uterine cancer	0.000752	0.00718	CbGeAlD
Dinoprostone—HPGDS—uterus—uterine cancer	0.000744	0.0071	CbGeAlD
Dinoprostone—Anaphylactoid reaction—Progesterone—uterine cancer	0.000744	0.0067	CcSEcCtD
Dinoprostone—PTGIR—epithelium—uterine cancer	0.000734	0.00701	CbGeAlD
Dinoprostone—PTGIR—smooth muscle tissue—uterine cancer	0.000708	0.00675	CbGeAlD
Dinoprostone—PTGER3—female gonad—uterine cancer	0.000705	0.00672	CbGeAlD
Dinoprostone—Hot flush—Medroxyprogesterone Acetate—uterine cancer	0.000697	0.00629	CcSEcCtD
Dinoprostone—Menopausal symptoms—Medroxyprogesterone Acetate—uterine cancer	0.000691	0.00623	CcSEcCtD
Dinoprostone—PTGFR—uterus—uterine cancer	0.000689	0.00657	CbGeAlD
Dinoprostone—SLCO1C1—renal system—uterine cancer	0.000683	0.00652	CbGeAlD
Dinoprostone—PTGIR—renal system—uterine cancer	0.000681	0.0065	CbGeAlD
Dinoprostone—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.000674	0.00608	CcSEcCtD
Dinoprostone—HPGDS—female reproductive system—uterine cancer	0.000669	0.00638	CbGeAlD
Dinoprostone—SLC22A11—renal system—uterine cancer	0.000664	0.00633	CbGeAlD
Dinoprostone—Cramp muscle—Progesterone—uterine cancer	0.000648	0.00584	CcSEcCtD
Dinoprostone—SLC22A7—renal system—uterine cancer	0.000648	0.00618	CbGeAlD
Dinoprostone—SLCO3A1—uterine cervix—uterine cancer	0.000643	0.00613	CbGeAlD
Dinoprostone—SLCO2A1—epithelium—uterine cancer	0.000642	0.00612	CbGeAlD
Dinoprostone—SLCO2A1—uterine cervix—uterine cancer	0.000636	0.00607	CbGeAlD
Dinoprostone—Asthma—Progesterone—uterine cancer	0.000622	0.00561	CcSEcCtD
Dinoprostone—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.00062	0.00559	CcSEcCtD
Dinoprostone—PTGFR—female reproductive system—uterine cancer	0.000619	0.0059	CbGeAlD
Dinoprostone—HPGDS—female gonad—uterine cancer	0.000609	0.00581	CbGeAlD
Dinoprostone—SLCO2A1—decidua—uterine cancer	0.000606	0.00578	CbGeAlD
Dinoprostone—Sweating increased—Progesterone—uterine cancer	0.000606	0.00546	CcSEcCtD
Dinoprostone—HPGDS—vagina—uterine cancer	0.000605	0.00577	CbGeAlD
Dinoprostone—SLCO3A1—renal system—uterine cancer	0.000601	0.00573	CbGeAlD
Dinoprostone—CYP11A1—decidua—uterine cancer	0.0006	0.00572	CbGeAlD
Dinoprostone—SLCO2A1—renal system—uterine cancer	0.000595	0.00568	CbGeAlD
Dinoprostone—Cramp muscle—Medroxyprogesterone Acetate—uterine cancer	0.000587	0.0053	CcSEcCtD
Dinoprostone—ABCC5—uterine cervix—uterine cancer	0.000582	0.00555	CbGeAlD
Dinoprostone—SLC22A2—renal system—uterine cancer	0.000577	0.0055	CbGeAlD
Dinoprostone—Pain—Carboplatin—uterine cancer	0.000576	0.00519	CcSEcCtD
Dinoprostone—SLCO2A1—endometrium—uterine cancer	0.000576	0.00549	CbGeAlD
Dinoprostone—Chest discomfort—Etoposide—uterine cancer	0.000573	0.00517	CcSEcCtD
Dinoprostone—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.000564	0.00508	CcSEcCtD
Dinoprostone—PTGFR—female gonad—uterine cancer	0.000563	0.00537	CbGeAlD
Dinoprostone—SLCO3A1—mammalian vulva—uterine cancer	0.000562	0.00536	CbGeAlD
Dinoprostone—Skin discolouration—Etoposide—uterine cancer	0.000562	0.00506	CcSEcCtD
Dinoprostone—SLCO4A1—decidua—uterine cancer	0.000558	0.00532	CbGeAlD
Dinoprostone—SLCO2A1—mammalian vulva—uterine cancer	0.000557	0.00531	CbGeAlD
Dinoprostone—ABCC5—decidua—uterine cancer	0.000555	0.00529	CbGeAlD
Dinoprostone—Bronchospasm—Medroxyprogesterone Acetate—uterine cancer	0.000555	0.005	CcSEcCtD
Dinoprostone—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.000549	0.00495	CcSEcCtD
Dinoprostone—SLCO4A1—renal system—uterine cancer	0.000548	0.00522	CbGeAlD
Dinoprostone—PTGIR—female reproductive system—uterine cancer	0.000546	0.0052	CbGeAlD
Dinoprostone—PTGER2—lymph node—uterine cancer	0.000545	0.0052	CbGeAlD
Dinoprostone—PTGER4—lymph node—uterine cancer	0.000535	0.0051	CbGeAlD
Dinoprostone—Body temperature increased—Carboplatin—uterine cancer	0.000532	0.0048	CcSEcCtD
Dinoprostone—SLC22A11—female reproductive system—uterine cancer	0.000532	0.00507	CbGeAlD
Dinoprostone—SLCO2A1—uterus—uterine cancer	0.00053	0.00506	CbGeAlD
Dinoprostone—SLCO4A1—endometrium—uterine cancer	0.00053	0.00505	CbGeAlD
Dinoprostone—SLC51A—lymph node—uterine cancer	0.000525	0.00501	CbGeAlD
Dinoprostone—Inflammation—Etoposide—uterine cancer	0.000523	0.00471	CcSEcCtD
Dinoprostone—SLCO4A1—mammalian vulva—uterine cancer	0.000512	0.00489	CbGeAlD
Dinoprostone—PTGIR—female gonad—uterine cancer	0.000496	0.00474	CbGeAlD
Dinoprostone—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.000496	0.00447	CcSEcCtD
Dinoprostone—Pharyngitis—Progesterone—uterine cancer	0.000494	0.00446	CcSEcCtD
Dinoprostone—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.000493	0.00444	CcSEcCtD
Dinoprostone—SLCO1B1—renal system—uterine cancer	0.000482	0.0046	CbGeAlD
Dinoprostone—SLCO3A1—female reproductive system—uterine cancer	0.000481	0.00459	CbGeAlD
Dinoprostone—SLCO2A1—female reproductive system—uterine cancer	0.000477	0.00455	CbGeAlD
Dinoprostone—CYP11A1—female reproductive system—uterine cancer	0.000472	0.0045	CbGeAlD
Dinoprostone—PTGER3—lymph node—uterine cancer	0.000453	0.00432	CbGeAlD
Dinoprostone—Angiopathy—Progesterone—uterine cancer	0.000452	0.00407	CcSEcCtD
Dinoprostone—Immune system disorder—Progesterone—uterine cancer	0.00045	0.00406	CcSEcCtD
Dinoprostone—Pharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.000448	0.00404	CcSEcCtD
Dinoprostone—SLCO4A1—female reproductive system—uterine cancer	0.000439	0.00418	CbGeAlD
Dinoprostone—SLCO3A1—female gonad—uterine cancer	0.000438	0.00418	CbGeAlD
Dinoprostone—SLCO3A1—vagina—uterine cancer	0.000435	0.00415	CbGeAlD
Dinoprostone—SLCO2B1—decidua—uterine cancer	0.000434	0.00414	CbGeAlD
Dinoprostone—SLCO2A1—female gonad—uterine cancer	0.000434	0.00414	CbGeAlD
Dinoprostone—SLCO2A1—vagina—uterine cancer	0.000431	0.00411	CbGeAlD
Dinoprostone—CYP11A1—female gonad—uterine cancer	0.000429	0.0041	CbGeAlD
Dinoprostone—SLCO2B1—renal system—uterine cancer	0.000426	0.00407	CbGeAlD
Dinoprostone—Tension—Progesterone—uterine cancer	0.000425	0.00383	CcSEcCtD
Dinoprostone—Back pain—Progesterone—uterine cancer	0.000419	0.00378	CcSEcCtD
Dinoprostone—Muscle spasms—Progesterone—uterine cancer	0.000417	0.00376	CcSEcCtD
Dinoprostone—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.000409	0.00369	CcSEcCtD
Dinoprostone—Vision blurred—Progesterone—uterine cancer	0.000409	0.00368	CcSEcCtD
Dinoprostone—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000408	0.00367	CcSEcCtD
Dinoprostone—SLC22A1—renal system—uterine cancer	0.000407	0.00389	CbGeAlD
Dinoprostone—Tremor—Progesterone—uterine cancer	0.000406	0.00366	CcSEcCtD
Dinoprostone—Chills—Medroxyprogesterone Acetate—uterine cancer	0.000405	0.00365	CcSEcCtD
Dinoprostone—ABCC5—female gonad—uterine cancer	0.000397	0.00379	CbGeAlD
Dinoprostone—SLCO4A1—vagina—uterine cancer	0.000397	0.00378	CbGeAlD
Dinoprostone—Laryngitis—Epirubicin—uterine cancer	0.000395	0.00356	CcSEcCtD
Dinoprostone—ABCC5—vagina—uterine cancer	0.000394	0.00376	CbGeAlD
Dinoprostone—SLCO1A2—renal system—uterine cancer	0.000392	0.00374	CbGeAlD
Dinoprostone—HPGDS—lymph node—uterine cancer	0.000391	0.00373	CbGeAlD
Dinoprostone—Syncope—Progesterone—uterine cancer	0.000389	0.0035	CcSEcCtD
Dinoprostone—SLCO1B1—female reproductive system—uterine cancer	0.000386	0.00368	CbGeAlD
Dinoprostone—Tension—Medroxyprogesterone Acetate—uterine cancer	0.000386	0.00348	CcSEcCtD
Dinoprostone—Loss of consciousness—Progesterone—uterine cancer	0.000381	0.00343	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Etoposide—uterine cancer	0.000381	0.00343	CcSEcCtD
Dinoprostone—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00038	0.00343	CcSEcCtD
Dinoprostone—SLCO2B1—uterus—uterine cancer	0.00038	0.00362	CbGeAlD
Dinoprostone—Cough—Progesterone—uterine cancer	0.000378	0.00341	CcSEcCtD
Dinoprostone—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.000378	0.0034	CcSEcCtD
Dinoprostone—ABCC4—renal system—uterine cancer	0.000377	0.0036	CbGeAlD
Dinoprostone—SLC22A8—renal system—uterine cancer	0.000374	0.00357	CbGeAlD
Dinoprostone—Hypertension—Progesterone—uterine cancer	0.000374	0.00337	CcSEcCtD
Dinoprostone—CYP19A1—endometrium—uterine cancer	0.00037	0.00353	CbGeAlD
Dinoprostone—Chest pain—Progesterone—uterine cancer	0.000369	0.00333	CcSEcCtD
Dinoprostone—Arthralgia—Progesterone—uterine cancer	0.000369	0.00333	CcSEcCtD
Dinoprostone—Myalgia—Progesterone—uterine cancer	0.000369	0.00333	CcSEcCtD
Dinoprostone—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.000368	0.00332	CcSEcCtD
Dinoprostone—Laryngitis—Doxorubicin—uterine cancer	0.000365	0.00329	CcSEcCtD
Dinoprostone—PTGFR—lymph node—uterine cancer	0.000362	0.00345	CbGeAlD
Dinoprostone—Anaphylactic shock—Progesterone—uterine cancer	0.000354	0.00319	CcSEcCtD
Dinoprostone—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.000352	0.00318	CcSEcCtD
Dinoprostone—Cardiac arrest—Etoposide—uterine cancer	0.00035	0.00316	CcSEcCtD
Dinoprostone—Pharyngitis—Dactinomycin—uterine cancer	0.000349	0.00315	CcSEcCtD
Dinoprostone—Shock—Progesterone—uterine cancer	0.000348	0.00314	CcSEcCtD
Dinoprostone—Tachycardia—Progesterone—uterine cancer	0.000345	0.00311	CcSEcCtD
Dinoprostone—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.000345	0.00311	CcSEcCtD
Dinoprostone—Hyperhidrosis—Progesterone—uterine cancer	0.000342	0.00308	CcSEcCtD
Dinoprostone—SLCO2B1—female reproductive system—uterine cancer	0.000341	0.00326	CbGeAlD
Dinoprostone—CYP19A1—uterus—uterine cancer	0.000341	0.00325	CbGeAlD
Dinoprostone—ABCC4—uterus—uterine cancer	0.000336	0.00321	CbGeAlD
Dinoprostone—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000334	0.00301	CcSEcCtD
Dinoprostone—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000334	0.00301	CcSEcCtD
Dinoprostone—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000334	0.00301	CcSEcCtD
Dinoprostone—Cramp muscle—Etoposide—uterine cancer	0.000332	0.00299	CcSEcCtD
Dinoprostone—Hypotension—Progesterone—uterine cancer	0.000331	0.00298	CcSEcCtD
Dinoprostone—Flushing—Dactinomycin—uterine cancer	0.000327	0.00294	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000322	0.00291	CcSEcCtD
Dinoprostone—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000321	0.00289	CcSEcCtD
Dinoprostone—SLCO1C1—lymph node—uterine cancer	0.00032	0.00305	CbGeAlD
Dinoprostone—PTGIR—lymph node—uterine cancer	0.000319	0.00304	CbGeAlD
Dinoprostone—Paraesthesia—Progesterone—uterine cancer	0.000318	0.00286	CcSEcCtD
Dinoprostone—Chills—Dactinomycin—uterine cancer	0.000316	0.00285	CcSEcCtD
Dinoprostone—Dyspnoea—Progesterone—uterine cancer	0.000315	0.00284	CcSEcCtD
Dinoprostone—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000315	0.00284	CcSEcCtD
Dinoprostone—Skin discolouration—Epirubicin—uterine cancer	0.000315	0.00284	CcSEcCtD
Dinoprostone—Bronchospasm—Etoposide—uterine cancer	0.000313	0.00282	CcSEcCtD
Dinoprostone—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000313	0.00282	CcSEcCtD
Dinoprostone—SLCO2B1—female gonad—uterine cancer	0.000311	0.00296	CbGeAlD
Dinoprostone—Sweating increased—Etoposide—uterine cancer	0.00031	0.00279	CcSEcCtD
Dinoprostone—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00031	0.00279	CcSEcCtD
Dinoprostone—CYP19A1—female reproductive system—uterine cancer	0.000307	0.00292	CbGeAlD
Dinoprostone—Pain—Progesterone—uterine cancer	0.000303	0.00273	CcSEcCtD
Dinoprostone—ABCC4—female reproductive system—uterine cancer	0.000302	0.00288	CbGeAlD
Dinoprostone—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.0003	0.0027	CcSEcCtD
Dinoprostone—SLC22A1—vagina—uterine cancer	0.000295	0.00281	CbGeAlD
Dinoprostone—Inflammation—Epirubicin—uterine cancer	0.000293	0.00264	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000292	0.00263	CcSEcCtD
Dinoprostone—Skin discolouration—Doxorubicin—uterine cancer	0.000291	0.00263	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Progesterone—uterine cancer	0.000289	0.00261	CcSEcCtD
Dinoprostone—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000288	0.0026	CcSEcCtD
Dinoprostone—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000286	0.00258	CcSEcCtD
Dinoprostone—Vaginal inflammation—Epirubicin—uterine cancer	0.000284	0.00256	CcSEcCtD
Dinoprostone—Hiccups—Epirubicin—uterine cancer	0.000284	0.00256	CcSEcCtD
Dinoprostone—SLCO3A1—lymph node—uterine cancer	0.000282	0.00269	CbGeAlD
Dinoprostone—Acute coronary syndrome—Etoposide—uterine cancer	0.00028	0.00252	CcSEcCtD
Dinoprostone—Body temperature increased—Progesterone—uterine cancer	0.00028	0.00252	CcSEcCtD
Dinoprostone—Abdominal pain—Progesterone—uterine cancer	0.00028	0.00252	CcSEcCtD
Dinoprostone—SLCO2A1—lymph node—uterine cancer	0.000279	0.00266	CbGeAlD
Dinoprostone—CYP19A1—female gonad—uterine cancer	0.000279	0.00266	CbGeAlD
Dinoprostone—Myocardial infarction—Etoposide—uterine cancer	0.000278	0.00251	CcSEcCtD
Dinoprostone—CYP11A1—lymph node—uterine cancer	0.000276	0.00263	CbGeAlD
Dinoprostone—ABCC4—female gonad—uterine cancer	0.000275	0.00262	CbGeAlD
Dinoprostone—Inflammation—Doxorubicin—uterine cancer	0.000271	0.00245	CcSEcCtD
Dinoprostone—Vaginal infection—Epirubicin—uterine cancer	0.000268	0.00242	CcSEcCtD
Dinoprostone—Vaginal inflammation—Doxorubicin—uterine cancer	0.000263	0.00237	CcSEcCtD
Dinoprostone—Hiccups—Doxorubicin—uterine cancer	0.000263	0.00237	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000262	0.00236	CcSEcCtD
Dinoprostone—Cramps of lower extremities—Epirubicin—uterine cancer	0.000261	0.00235	CcSEcCtD
Dinoprostone—Myalgia—Dactinomycin—uterine cancer	0.000261	0.00235	CcSEcCtD
Dinoprostone—Hypersensitivity—Progesterone—uterine cancer	0.000261	0.00235	CcSEcCtD
Dinoprostone—SLCO4A1—lymph node—uterine cancer	0.000257	0.00245	CbGeAlD
Dinoprostone—CYP1A2—renal system—uterine cancer	0.000256	0.00245	CbGeAlD
Dinoprostone—ABCC5—lymph node—uterine cancer	0.000255	0.00243	CbGeAlD
Dinoprostone—Asthenia—Progesterone—uterine cancer	0.000254	0.00229	CcSEcCtD
Dinoprostone—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000253	0.00228	CcSEcCtD
Dinoprostone—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000253	0.00228	CcSEcCtD
Dinoprostone—Hypertonia—Epirubicin—uterine cancer	0.000249	0.00225	CcSEcCtD
Dinoprostone—Vaginal infection—Doxorubicin—uterine cancer	0.000248	0.00224	CcSEcCtD
Dinoprostone—Diarrhoea—Progesterone—uterine cancer	0.000242	0.00218	CcSEcCtD
Dinoprostone—Cramps of lower extremities—Doxorubicin—uterine cancer	0.000242	0.00218	CcSEcCtD
Dinoprostone—Flushing—Etoposide—uterine cancer	0.000236	0.00213	CcSEcCtD
Dinoprostone—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000236	0.00213	CcSEcCtD
Dinoprostone—Dizziness—Progesterone—uterine cancer	0.000234	0.00211	CcSEcCtD
Dinoprostone—Angiopathy—Etoposide—uterine cancer	0.000231	0.00208	CcSEcCtD
Dinoprostone—Hypertonia—Doxorubicin—uterine cancer	0.000231	0.00208	CcSEcCtD
Dinoprostone—Immune system disorder—Etoposide—uterine cancer	0.00023	0.00207	CcSEcCtD
Dinoprostone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00023	0.00207	CcSEcCtD
Dinoprostone—Eye pain—Epirubicin—uterine cancer	0.000229	0.00206	CcSEcCtD
Dinoprostone—Chills—Etoposide—uterine cancer	0.000229	0.00206	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000228	0.00205	CcSEcCtD
Dinoprostone—Vomiting—Progesterone—uterine cancer	0.000225	0.00203	CcSEcCtD
Dinoprostone—Rash—Progesterone—uterine cancer	0.000223	0.00201	CcSEcCtD
Dinoprostone—Dermatitis—Progesterone—uterine cancer	0.000223	0.00201	CcSEcCtD
Dinoprostone—Headache—Progesterone—uterine cancer	0.000222	0.002	CcSEcCtD
Dinoprostone—Hot flush—Epirubicin—uterine cancer	0.000221	0.00199	CcSEcCtD
Dinoprostone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000219	0.00198	CcSEcCtD
Dinoprostone—Menopausal symptoms—Epirubicin—uterine cancer	0.000219	0.00197	CcSEcCtD
Dinoprostone—Back pain—Etoposide—uterine cancer	0.000215	0.00193	CcSEcCtD
Dinoprostone—Pain—Dactinomycin—uterine cancer	0.000214	0.00193	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000213	0.00192	CcSEcCtD
Dinoprostone—Muscle spasms—Etoposide—uterine cancer	0.000213	0.00192	CcSEcCtD
Dinoprostone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000212	0.00191	CcSEcCtD
Dinoprostone—Eye pain—Doxorubicin—uterine cancer	0.000212	0.00191	CcSEcCtD
Dinoprostone—Nausea—Progesterone—uterine cancer	0.00021	0.00189	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000205	0.00184	CcSEcCtD
Dinoprostone—Hot flush—Doxorubicin—uterine cancer	0.000204	0.00184	CcSEcCtD
Dinoprostone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000204	0.00184	CcSEcCtD
Dinoprostone—Menopausal symptoms—Doxorubicin—uterine cancer	0.000202	0.00182	CcSEcCtD
Dinoprostone—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000202	0.00182	CcSEcCtD
Dinoprostone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000202	0.00182	CcSEcCtD
Dinoprostone—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000201	0.00181	CcSEcCtD
Dinoprostone—SLCO2B1—lymph node—uterine cancer	0.0002	0.0019	CbGeAlD
Dinoprostone—Abdominal pain—Dactinomycin—uterine cancer	0.000198	0.00178	CcSEcCtD
Dinoprostone—Body temperature increased—Dactinomycin—uterine cancer	0.000198	0.00178	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000197	0.00178	CcSEcCtD
Dinoprostone—Cardiac arrest—Epirubicin—uterine cancer	0.000196	0.00177	CcSEcCtD
Dinoprostone—Loss of consciousness—Etoposide—uterine cancer	0.000195	0.00176	CcSEcCtD
Dinoprostone—Cough—Etoposide—uterine cancer	0.000194	0.00174	CcSEcCtD
Dinoprostone—Dehydration—Epirubicin—uterine cancer	0.000192	0.00173	CcSEcCtD
Dinoprostone—Hypertension—Etoposide—uterine cancer	0.000191	0.00173	CcSEcCtD
Dinoprostone—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00019	0.00172	CcSEcCtD
Dinoprostone—Chest pain—Etoposide—uterine cancer	0.000189	0.0017	CcSEcCtD
Dinoprostone—Hypersensitivity—Dactinomycin—uterine cancer	0.000184	0.00166	CcSEcCtD
Dinoprostone—Cardiac arrest—Doxorubicin—uterine cancer	0.000182	0.00164	CcSEcCtD
Dinoprostone—Anaphylactic shock—Etoposide—uterine cancer	0.000181	0.00163	CcSEcCtD
Dinoprostone—Asthenia—Dactinomycin—uterine cancer	0.000179	0.00162	CcSEcCtD
Dinoprostone—CYP19A1—lymph node—uterine cancer	0.000179	0.00171	CbGeAlD
Dinoprostone—Asthma—Epirubicin—uterine cancer	0.000178	0.00161	CcSEcCtD
Dinoprostone—Dehydration—Doxorubicin—uterine cancer	0.000178	0.0016	CcSEcCtD
Dinoprostone—ABCC4—lymph node—uterine cancer	0.000177	0.00169	CbGeAlD
Dinoprostone—Tachycardia—Etoposide—uterine cancer	0.000177	0.00159	CcSEcCtD
Dinoprostone—Hyperhidrosis—Etoposide—uterine cancer	0.000175	0.00158	CcSEcCtD
Dinoprostone—Diarrhoea—Dactinomycin—uterine cancer	0.000171	0.00154	CcSEcCtD
Dinoprostone—Hypotension—Etoposide—uterine cancer	0.000169	0.00152	CcSEcCtD
Dinoprostone—Asthma—Doxorubicin—uterine cancer	0.000165	0.00149	CcSEcCtD
Dinoprostone—Paraesthesia—Etoposide—uterine cancer	0.000163	0.00147	CcSEcCtD
Dinoprostone—Dyspnoea—Etoposide—uterine cancer	0.000161	0.00145	CcSEcCtD
Dinoprostone—Vomiting—Dactinomycin—uterine cancer	0.000159	0.00143	CcSEcCtD
Dinoprostone—Rash—Dactinomycin—uterine cancer	0.000158	0.00142	CcSEcCtD
Dinoprostone—Pain—Etoposide—uterine cancer	0.000155	0.0014	CcSEcCtD
Dinoprostone—Nausea—Dactinomycin—uterine cancer	0.000149	0.00134	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Etoposide—uterine cancer	0.000148	0.00133	CcSEcCtD
Dinoprostone—Abdominal pain—Etoposide—uterine cancer	0.000143	0.00129	CcSEcCtD
Dinoprostone—Body temperature increased—Etoposide—uterine cancer	0.000143	0.00129	CcSEcCtD
Dinoprostone—Pharyngitis—Epirubicin—uterine cancer	0.000142	0.00128	CcSEcCtD
Dinoprostone—Hypersensitivity—Etoposide—uterine cancer	0.000133	0.0012	CcSEcCtD
Dinoprostone—Flushing—Epirubicin—uterine cancer	0.000133	0.00119	CcSEcCtD
Dinoprostone—Pharyngitis—Doxorubicin—uterine cancer	0.000131	0.00118	CcSEcCtD
Dinoprostone—Asthenia—Etoposide—uterine cancer	0.00013	0.00117	CcSEcCtD
Dinoprostone—Angiopathy—Epirubicin—uterine cancer	0.00013	0.00117	CcSEcCtD
Dinoprostone—Immune system disorder—Epirubicin—uterine cancer	0.000129	0.00116	CcSEcCtD
Dinoprostone—Chills—Epirubicin—uterine cancer	0.000128	0.00116	CcSEcCtD
Dinoprostone—Arrhythmia—Epirubicin—uterine cancer	0.000128	0.00115	CcSEcCtD
Dinoprostone—Diarrhoea—Etoposide—uterine cancer	0.000124	0.00112	CcSEcCtD
Dinoprostone—Flushing—Doxorubicin—uterine cancer	0.000123	0.00111	CcSEcCtD
Dinoprostone—Tension—Epirubicin—uterine cancer	0.000122	0.0011	CcSEcCtD
Dinoprostone—Back pain—Epirubicin—uterine cancer	0.00012	0.00108	CcSEcCtD
Dinoprostone—Angiopathy—Doxorubicin—uterine cancer	0.00012	0.00108	CcSEcCtD
Dinoprostone—Dizziness—Etoposide—uterine cancer	0.00012	0.00108	CcSEcCtD
Dinoprostone—Muscle spasms—Epirubicin—uterine cancer	0.00012	0.00108	CcSEcCtD
Dinoprostone—Immune system disorder—Doxorubicin—uterine cancer	0.000119	0.00108	CcSEcCtD
Dinoprostone—Chills—Doxorubicin—uterine cancer	0.000119	0.00107	CcSEcCtD
Dinoprostone—Arrhythmia—Doxorubicin—uterine cancer	0.000118	0.00106	CcSEcCtD
Dinoprostone—Vision blurred—Epirubicin—uterine cancer	0.000117	0.00106	CcSEcCtD
Dinoprostone—Vomiting—Etoposide—uterine cancer	0.000115	0.00104	CcSEcCtD
Dinoprostone—Rash—Etoposide—uterine cancer	0.000114	0.00103	CcSEcCtD
Dinoprostone—Dermatitis—Etoposide—uterine cancer	0.000114	0.00103	CcSEcCtD
Dinoprostone—Headache—Etoposide—uterine cancer	0.000113	0.00102	CcSEcCtD
Dinoprostone—Tension—Doxorubicin—uterine cancer	0.000113	0.00102	CcSEcCtD
Dinoprostone—Syncope—Epirubicin—uterine cancer	0.000111	0.001	CcSEcCtD
Dinoprostone—Back pain—Doxorubicin—uterine cancer	0.000111	0.001	CcSEcCtD
Dinoprostone—Muscle spasms—Doxorubicin—uterine cancer	0.000111	0.000997	CcSEcCtD
Dinoprostone—Loss of consciousness—Epirubicin—uterine cancer	0.000109	0.000985	CcSEcCtD
Dinoprostone—Cough—Epirubicin—uterine cancer	0.000108	0.000978	CcSEcCtD
Dinoprostone—Vision blurred—Doxorubicin—uterine cancer	0.000108	0.000977	CcSEcCtD
Dinoprostone—Nausea—Etoposide—uterine cancer	0.000108	0.000969	CcSEcCtD
Dinoprostone—Hypertension—Epirubicin—uterine cancer	0.000107	0.000968	CcSEcCtD
Dinoprostone—Myalgia—Epirubicin—uterine cancer	0.000106	0.000954	CcSEcCtD
Dinoprostone—Arthralgia—Epirubicin—uterine cancer	0.000106	0.000954	CcSEcCtD
Dinoprostone—Chest pain—Epirubicin—uterine cancer	0.000106	0.000954	CcSEcCtD
Dinoprostone—Syncope—Doxorubicin—uterine cancer	0.000103	0.00093	CcSEcCtD
Dinoprostone—Anaphylactic shock—Epirubicin—uterine cancer	0.000101	0.000915	CcSEcCtD
Dinoprostone—Loss of consciousness—Doxorubicin—uterine cancer	0.000101	0.000911	CcSEcCtD
Dinoprostone—Cough—Doxorubicin—uterine cancer	0.0001	0.000905	CcSEcCtD
Dinoprostone—Shock—Epirubicin—uterine cancer	9.98e-05	0.0009	CcSEcCtD
Dinoprostone—Hypertension—Doxorubicin—uterine cancer	9.93e-05	0.000895	CcSEcCtD
Dinoprostone—Tachycardia—Epirubicin—uterine cancer	9.9e-05	0.000893	CcSEcCtD
Dinoprostone—Hyperhidrosis—Epirubicin—uterine cancer	9.81e-05	0.000884	CcSEcCtD
Dinoprostone—Myalgia—Doxorubicin—uterine cancer	9.79e-05	0.000883	CcSEcCtD
Dinoprostone—Arthralgia—Doxorubicin—uterine cancer	9.79e-05	0.000883	CcSEcCtD
Dinoprostone—Chest pain—Doxorubicin—uterine cancer	9.79e-05	0.000883	CcSEcCtD
Dinoprostone—Hypotension—Epirubicin—uterine cancer	9.48e-05	0.000855	CcSEcCtD
Dinoprostone—Anaphylactic shock—Doxorubicin—uterine cancer	9.39e-05	0.000846	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Epirubicin—uterine cancer	9.24e-05	0.000833	CcSEcCtD
Dinoprostone—Shock—Doxorubicin—uterine cancer	9.24e-05	0.000833	CcSEcCtD
Dinoprostone—Tachycardia—Doxorubicin—uterine cancer	9.16e-05	0.000826	CcSEcCtD
Dinoprostone—Paraesthesia—Epirubicin—uterine cancer	9.11e-05	0.000821	CcSEcCtD
Dinoprostone—Hyperhidrosis—Doxorubicin—uterine cancer	9.08e-05	0.000818	CcSEcCtD
Dinoprostone—Dyspnoea—Epirubicin—uterine cancer	9.05e-05	0.000815	CcSEcCtD
Dinoprostone—Hypotension—Doxorubicin—uterine cancer	8.77e-05	0.000791	CcSEcCtD
Dinoprostone—Pain—Epirubicin—uterine cancer	8.68e-05	0.000782	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	8.55e-05	0.000771	CcSEcCtD
Dinoprostone—Paraesthesia—Doxorubicin—uterine cancer	8.43e-05	0.00076	CcSEcCtD
Dinoprostone—Dyspnoea—Doxorubicin—uterine cancer	8.37e-05	0.000754	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Epirubicin—uterine cancer	8.3e-05	0.000748	CcSEcCtD
Dinoprostone—Pain—Doxorubicin—uterine cancer	8.03e-05	0.000724	CcSEcCtD
Dinoprostone—Abdominal pain—Epirubicin—uterine cancer	8.02e-05	0.000723	CcSEcCtD
Dinoprostone—Body temperature increased—Epirubicin—uterine cancer	8.02e-05	0.000723	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Doxorubicin—uterine cancer	7.68e-05	0.000692	CcSEcCtD
Dinoprostone—Hypersensitivity—Epirubicin—uterine cancer	7.48e-05	0.000674	CcSEcCtD
Dinoprostone—Abdominal pain—Doxorubicin—uterine cancer	7.42e-05	0.000669	CcSEcCtD
Dinoprostone—Body temperature increased—Doxorubicin—uterine cancer	7.42e-05	0.000669	CcSEcCtD
Dinoprostone—Asthenia—Epirubicin—uterine cancer	7.28e-05	0.000656	CcSEcCtD
Dinoprostone—Diarrhoea—Epirubicin—uterine cancer	6.94e-05	0.000626	CcSEcCtD
Dinoprostone—Hypersensitivity—Doxorubicin—uterine cancer	6.92e-05	0.000623	CcSEcCtD
Dinoprostone—Asthenia—Doxorubicin—uterine cancer	6.74e-05	0.000607	CcSEcCtD
Dinoprostone—Dizziness—Epirubicin—uterine cancer	6.71e-05	0.000605	CcSEcCtD
Dinoprostone—Vomiting—Epirubicin—uterine cancer	6.45e-05	0.000582	CcSEcCtD
Dinoprostone—Diarrhoea—Doxorubicin—uterine cancer	6.42e-05	0.000579	CcSEcCtD
Dinoprostone—Rash—Epirubicin—uterine cancer	6.4e-05	0.000577	CcSEcCtD
Dinoprostone—Dermatitis—Epirubicin—uterine cancer	6.39e-05	0.000576	CcSEcCtD
Dinoprostone—Headache—Epirubicin—uterine cancer	6.36e-05	0.000573	CcSEcCtD
Dinoprostone—Dizziness—Doxorubicin—uterine cancer	6.21e-05	0.00056	CcSEcCtD
Dinoprostone—Nausea—Epirubicin—uterine cancer	6.03e-05	0.000543	CcSEcCtD
Dinoprostone—Vomiting—Doxorubicin—uterine cancer	5.97e-05	0.000538	CcSEcCtD
Dinoprostone—Rash—Doxorubicin—uterine cancer	5.92e-05	0.000534	CcSEcCtD
Dinoprostone—Dermatitis—Doxorubicin—uterine cancer	5.91e-05	0.000533	CcSEcCtD
Dinoprostone—Headache—Doxorubicin—uterine cancer	5.88e-05	0.00053	CcSEcCtD
Dinoprostone—Nausea—Doxorubicin—uterine cancer	5.58e-05	0.000503	CcSEcCtD
Dinoprostone—PTGER4—Signaling Pathways—CXCL8—uterine cancer	1.67e-05	0.00027	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SMAD3—uterine cancer	1.67e-05	0.000269	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—HRAS—uterine cancer	1.66e-05	0.000268	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—PTEN—uterine cancer	1.66e-05	0.000267	CbGpPWpGaD
Dinoprostone—ABCC4—Platelet activation, signaling and aggregation—AKT1—uterine cancer	1.64e-05	0.000265	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SMAD3—uterine cancer	1.63e-05	0.000264	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SMAD3—uterine cancer	1.63e-05	0.000264	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CDKN1B—uterine cancer	1.63e-05	0.000264	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—DCN—uterine cancer	1.63e-05	0.000262	CbGpPWpGaD
Dinoprostone—PTGER2—GPCR downstream signaling—PIK3CA—uterine cancer	1.63e-05	0.000262	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CYP11A1—uterine cancer	1.62e-05	0.000261	CbGpPWpGaD
Dinoprostone—PTGER4—GPCR downstream signaling—AKT1—uterine cancer	1.62e-05	0.000261	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.61e-05	0.00026	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—HRAS—uterine cancer	1.61e-05	0.000259	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—KRAS—uterine cancer	1.61e-05	0.000259	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—CXCL8—uterine cancer	1.61e-05	0.000259	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AKR1C1—uterine cancer	1.61e-05	0.000259	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CCL2—uterine cancer	1.6e-05	0.000259	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—FGFR2—uterine cancer	1.59e-05	0.000257	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—EP300—uterine cancer	1.58e-05	0.000255	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—CXCL8—uterine cancer	1.57e-05	0.000253	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—CXCL8—uterine cancer	1.57e-05	0.000253	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—FGFR2—uterine cancer	1.56e-05	0.000251	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—FGFR2—uterine cancer	1.56e-05	0.000251	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—CTNNB1—uterine cancer	1.54e-05	0.000249	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—MTHFR—uterine cancer	1.54e-05	0.000249	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—RRM2—uterine cancer	1.54e-05	0.000248	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CYP11A1—uterine cancer	1.53e-05	0.000247	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—AKR1C3—uterine cancer	1.53e-05	0.000247	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—PTEN—uterine cancer	1.51e-05	0.000243	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—PIK3CA—uterine cancer	1.5e-05	0.000242	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—DCN—uterine cancer	1.49e-05	0.00024	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—KRAS—uterine cancer	1.48e-05	0.000239	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—PIK3CA—uterine cancer	1.48e-05	0.000238	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling by GPCR—AKT1—uterine cancer	1.47e-05	0.000237	CbGpPWpGaD
Dinoprostone—SLC22A2—Transmission across Chemical Synapses—HRAS—uterine cancer	1.46e-05	0.000236	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—ERBB2—uterine cancer	1.45e-05	0.000234	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AKR1C3—uterine cancer	1.45e-05	0.000233	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—EP300—uterine cancer	1.44e-05	0.000231	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—RRM2—uterine cancer	1.43e-05	0.000231	CbGpPWpGaD
Dinoprostone—PTGIR—Hemostasis—AKT1—uterine cancer	1.42e-05	0.000229	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.42e-05	0.000228	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.42e-05	0.000228	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CYP11A1—uterine cancer	1.4e-05	0.000226	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—EP300—uterine cancer	1.4e-05	0.000226	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—DCN—uterine cancer	1.39e-05	0.000224	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.38e-05	0.000222	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CXCL8—uterine cancer	1.37e-05	0.000222	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—HRAS—uterine cancer	1.37e-05	0.00022	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ESR1—uterine cancer	1.36e-05	0.00022	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—PIK3CA—uterine cancer	1.36e-05	0.00022	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmission across Chemical Synapses—HRAS—uterine cancer	1.36e-05	0.00022	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—VEGFA—uterine cancer	1.36e-05	0.000219	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—MTHFR—uterine cancer	1.35e-05	0.000218	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—NRAS—uterine cancer	1.34e-05	0.000217	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CDKN1B—uterine cancer	1.34e-05	0.000216	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—ERBB2—uterine cancer	1.34e-05	0.000216	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ESR1—uterine cancer	1.33e-05	0.000215	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ESR1—uterine cancer	1.33e-05	0.000215	CbGpPWpGaD
Dinoprostone—PTGER2—GPCR downstream signaling—AKT1—uterine cancer	1.33e-05	0.000214	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AKR1C3—uterine cancer	1.33e-05	0.000214	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—VEGFA—uterine cancer	1.33e-05	0.000214	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CYP19A1—uterine cancer	1.32e-05	0.000213	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—STK11—uterine cancer	1.32e-05	0.000213	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—NRAS—uterine cancer	1.31e-05	0.000211	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CYP11A1—uterine cancer	1.31e-05	0.000211	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.3e-05	0.000209	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—NRAS—uterine cancer	1.29e-05	0.000208	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CXCL8—uterine cancer	1.27e-05	0.000205	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—CTNNB1—uterine cancer	1.27e-05	0.000205	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—NRAS—uterine cancer	1.26e-05	0.000203	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—NRAS—uterine cancer	1.26e-05	0.000203	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—HRAS—uterine cancer	1.26e-05	0.000203	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CDKN1B—uterine cancer	1.24e-05	0.0002	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.24e-05	0.0002	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AKR1C3—uterine cancer	1.24e-05	0.000199	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PTEN—uterine cancer	1.24e-05	0.000199	CbGpPWpGaD
Dinoprostone—PTGER3—GPCR downstream signaling—AKT1—uterine cancer	1.23e-05	0.000198	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling by GPCR—AKT1—uterine cancer	1.21e-05	0.000194	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—ERBB2—uterine cancer	1.2e-05	0.000194	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCL2—uterine cancer	1.2e-05	0.000193	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—STK11—uterine cancer	1.19e-05	0.000192	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.19e-05	0.000192	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.18e-05	0.00019	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—EP300—uterine cancer	1.18e-05	0.00019	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCL2—uterine cancer	1.17e-05	0.000189	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCL2—uterine cancer	1.17e-05	0.000189	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CTNNB1—uterine cancer	1.17e-05	0.000189	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—PIK3CA—uterine cancer	1.17e-05	0.000189	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—KRAS—uterine cancer	1.16e-05	0.000186	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PTEN—uterine cancer	1.14e-05	0.000184	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CYP19A1—uterine cancer	1.13e-05	0.000182	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—STK11—uterine cancer	1.13e-05	0.000182	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—KRAS—uterine cancer	1.13e-05	0.000182	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—PIK3CA—uterine cancer	1.12e-05	0.000181	CbGpPWpGaD
Dinoprostone—SLC22A2—Neuronal System—HRAS—uterine cancer	1.12e-05	0.000181	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.12e-05	0.00018	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—VEGFA—uterine cancer	1.12e-05	0.00018	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CDKN1B—uterine cancer	1.11e-05	0.00018	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling by GPCR—AKT1—uterine cancer	1.11e-05	0.000179	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—KRAS—uterine cancer	1.11e-05	0.000179	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—NRAS—uterine cancer	1.1e-05	0.000178	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—PIK3CA—uterine cancer	1.1e-05	0.000177	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—PIK3CA—uterine cancer	1.1e-05	0.000177	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—EP300—uterine cancer	1.09e-05	0.000175	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—KRAS—uterine cancer	1.09e-05	0.000175	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—KRAS—uterine cancer	1.09e-05	0.000175	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.07e-05	0.000172	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—PIK3CA—uterine cancer	1.06e-05	0.000171	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.06e-05	0.000171	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CTNNB1—uterine cancer	1.05e-05	0.00017	CbGpPWpGaD
Dinoprostone—SLC22A1—Neuronal System—HRAS—uterine cancer	1.04e-05	0.000168	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—PIK3CA—uterine cancer	1.04e-05	0.000167	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—STK11—uterine cancer	1.03e-05	0.000167	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CYP19A1—uterine cancer	1.03e-05	0.000167	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—VEGFA—uterine cancer	1.03e-05	0.000166	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TP53—uterine cancer	1.03e-05	0.000166	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PTEN—uterine cancer	1.03e-05	0.000165	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.02e-05	0.000165	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—STAR—uterine cancer	1.02e-05	0.000165	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—PIK3CA—uterine cancer	1.02e-05	0.000164	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—NRAS—uterine cancer	1.02e-05	0.000164	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.01e-05	0.000163	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.01e-05	0.000163	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TP53—uterine cancer	1e-05	0.000162	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ERBB2—uterine cancer	1e-05	0.000161	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—PIK3CA—uterine cancer	9.97e-06	0.000161	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—PIK3CA—uterine cancer	9.97e-06	0.000161	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—MTHFR—uterine cancer	9.91e-06	0.00016	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—HRAS—uterine cancer	9.83e-06	0.000158	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ERBB2—uterine cancer	9.79e-06	0.000158	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ERBB2—uterine cancer	9.79e-06	0.000158	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—EP300—uterine cancer	9.78e-06	0.000158	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CYP19A1—uterine cancer	9.63e-06	0.000155	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—STK11—uterine cancer	9.63e-06	0.000155	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—HRAS—uterine cancer	9.58e-06	0.000155	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—AKT1—uterine cancer	9.56e-06	0.000154	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—KRAS—uterine cancer	9.49e-06	0.000153	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CXCL8—uterine cancer	9.49e-06	0.000153	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—HRAS—uterine cancer	9.43e-06	0.000152	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CXCL8—uterine cancer	9.29e-06	0.00015	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CXCL8—uterine cancer	9.29e-06	0.00015	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CDKN1B—uterine cancer	9.26e-06	0.000149	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—HRAS—uterine cancer	9.23e-06	0.000149	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—HRAS—uterine cancer	9.23e-06	0.000149	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—AKT1—uterine cancer	9.16e-06	0.000148	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—NRAS—uterine cancer	9.15e-06	0.000148	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CDKN1B—uterine cancer	9.07e-06	0.000146	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CDKN1B—uterine cancer	9.07e-06	0.000146	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—AKT1—uterine cancer	8.97e-06	0.000145	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—AKT1—uterine cancer	8.97e-06	0.000145	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—MTHFR—uterine cancer	8.96e-06	0.000144	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—KRAS—uterine cancer	8.76e-06	0.000141	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CTNNB1—uterine cancer	8.75e-06	0.000141	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.73e-06	0.000141	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PIK3CA—uterine cancer	8.72e-06	0.000141	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—AKT1—uterine cancer	8.68e-06	0.00014	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTEN—uterine cancer	8.59e-06	0.000138	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CTNNB1—uterine cancer	8.57e-06	0.000138	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CTNNB1—uterine cancer	8.57e-06	0.000138	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PTEN—uterine cancer	8.53e-06	0.000138	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—MTHFR—uterine cancer	8.47e-06	0.000137	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—AKT1—uterine cancer	8.46e-06	0.000136	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TP53—uterine cancer	8.44e-06	0.000136	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PTEN—uterine cancer	8.35e-06	0.000135	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PTEN—uterine cancer	8.35e-06	0.000135	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—AKT1—uterine cancer	8.32e-06	0.000134	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—EP300—uterine cancer	8.19e-06	0.000132	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—AKT1—uterine cancer	8.15e-06	0.000131	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—AKT1—uterine cancer	8.15e-06	0.000131	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—EP300—uterine cancer	8.14e-06	0.000131	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—HRAS—uterine cancer	8.07e-06	0.00013	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PIK3CA—uterine cancer	8.05e-06	0.00013	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—POLD1—uterine cancer	8.03e-06	0.00013	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—EP300—uterine cancer	7.96e-06	0.000128	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—EP300—uterine cancer	7.96e-06	0.000128	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.89e-06	0.000127	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—KRAS—uterine cancer	7.87e-06	0.000127	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TP53—uterine cancer	7.79e-06	0.000126	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—MTHFR—uterine cancer	7.77e-06	0.000125	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VEGFA—uterine cancer	7.71e-06	0.000124	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NRAS—uterine cancer	7.61e-06	0.000123	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VEGFA—uterine cancer	7.54e-06	0.000122	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VEGFA—uterine cancer	7.54e-06	0.000122	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTEN—uterine cancer	7.52e-06	0.000121	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKR1C1—uterine cancer	7.51e-06	0.000121	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.47e-06	0.00012	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NRAS—uterine cancer	7.45e-06	0.00012	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NRAS—uterine cancer	7.45e-06	0.00012	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—HRAS—uterine cancer	7.45e-06	0.00012	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—MTHFR—uterine cancer	7.24e-06	0.000117	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PIK3CA—uterine cancer	7.23e-06	0.000117	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—EP300—uterine cancer	7.17e-06	0.000116	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—AKT1—uterine cancer	7.12e-06	0.000115	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—RRM2—uterine cancer	6.7e-06	0.000108	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—HRAS—uterine cancer	6.69e-06	0.000108	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—AKT1—uterine cancer	6.57e-06	0.000106	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—KRAS—uterine cancer	6.55e-06	0.000106	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—DCN—uterine cancer	6.5e-06	0.000105	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—KRAS—uterine cancer	6.41e-06	0.000103	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—KRAS—uterine cancer	6.41e-06	0.000103	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP11A1—uterine cancer	6.13e-06	9.88e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PIK3CA—uterine cancer	6.06e-06	9.77e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PIK3CA—uterine cancer	6.02e-06	9.7e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—AKT1—uterine cancer	5.91e-06	9.53e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PIK3CA—uterine cancer	5.89e-06	9.5e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PIK3CA—uterine cancer	5.89e-06	9.5e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TP53—uterine cancer	5.82e-06	9.39e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKR1C3—uterine cancer	5.78e-06	9.33e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TP53—uterine cancer	5.7e-06	9.19e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TP53—uterine cancer	5.7e-06	9.19e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—HRAS—uterine cancer	5.57e-06	8.98e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTEN—uterine cancer	5.51e-06	8.89e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—HRAS—uterine cancer	5.45e-06	8.79e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—HRAS—uterine cancer	5.45e-06	8.79e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3CA—uterine cancer	5.31e-06	8.56e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—EP300—uterine cancer	5.26e-06	8.48e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTEN—uterine cancer	4.98e-06	8.03e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—AKT1—uterine cancer	4.95e-06	7.98e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—AKT1—uterine cancer	4.92e-06	7.93e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—AKT1—uterine cancer	4.81e-06	7.76e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—AKT1—uterine cancer	4.81e-06	7.76e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—EP300—uterine cancer	4.75e-06	7.66e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTEN—uterine cancer	4.71e-06	7.6e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—STK11—uterine cancer	4.51e-06	7.27e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP19A1—uterine cancer	4.51e-06	7.27e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—EP300—uterine cancer	4.5e-06	7.25e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—AKT1—uterine cancer	4.33e-06	6.99e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTEN—uterine cancer	4.32e-06	6.97e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.23e-06	6.82e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—EP300—uterine cancer	4.12e-06	6.64e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.03e-06	6.51e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTEN—uterine cancer	4.03e-06	6.49e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CA—uterine cancer	3.89e-06	6.27e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—EP300—uterine cancer	3.84e-06	6.19e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CA—uterine cancer	3.51e-06	5.67e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—MTHFR—uterine cancer	3.39e-06	5.46e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CA—uterine cancer	3.33e-06	5.36e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—AKT1—uterine cancer	3.18e-06	5.12e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CA—uterine cancer	3.05e-06	4.91e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.98e-06	4.81e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—AKT1—uterine cancer	2.87e-06	4.63e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CA—uterine cancer	2.84e-06	4.58e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AKT1—uterine cancer	2.72e-06	4.38e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AKT1—uterine cancer	2.49e-06	4.01e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AKT1—uterine cancer	2.32e-06	3.74e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTEN—uterine cancer	1.88e-06	3.04e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—EP300—uterine cancer	1.8e-06	2.9e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.33e-06	2.14e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKT1—uterine cancer	1.09e-06	1.75e-05	CbGpPWpGaD
